Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Thrombectomy: Features

Michael Lichtenberg MD
LINC 2024
Aspirex Could Push Through to New Era in Mechanical Thrombectomy
05/28/2024

Michael Lichtenberg, MD
Arnsberg Vascular Clinic, Arnsberg, Germany

Michael Lichtenberg, MD Arnsberg Vasc...
A study of a mechanical thrombectomy device in the treatment of acute venous occlusions was given a 24-month update today by Michael Lichtenberg, an interventional radiologist and head of the Arnsberg Vascular Clinic.
A study of a mechanical thrombectomy device in the treatment of acute venous occlusions was given a 24-month update today by Michael Lichtenberg, an interventional radiologist and head of the Arnsberg Vascular Clinic.
A study of a mechanical...
05/28/2024
Vascular Disease Management
Aspiration Thrombectomy
Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for Vessels of the Peripheral Arterial and Venous Systems
04/22/2024

Expanse Medical Press Release

Expanse Medical Press Release
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the...
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the...
PLEASANTON, Calif., April 22,...
04/22/2024
Vascular Disease Management
Case Report
Mechanical Thrombectomy for Acute Ischemic Stroke Associated With an Ipsilateral Internal Carotid Artery Web
09/21/2023
This case report highlights the clinical trajectory of a previously healthy young man who presented with acute right hemiplegia due to left middle cerebral artery occlusion. The patient underwent successful mechanical thrombectomy.
This case report highlights the clinical trajectory of a previously healthy young man who presented with acute right hemiplegia due to left middle cerebral artery occlusion. The patient underwent successful mechanical thrombectomy.
This case report highlights the...
09/21/2023
Vascular Disease Management
Case Report
A Rare Case of Simultaneous Acute Embolic Occlusions of the Right Upper and Lower Extremity, Recanalized With Endovascular Thrombectomy
06/19/2023
Endovascular thrombectomy of acute simultaneous embolism of the right upper and lower extremity.
Endovascular thrombectomy of acute simultaneous embolism of the right upper and lower extremity.
Endovascular thrombectomy of...
06/19/2023
Vascular Disease Management
Original Research
Acute Limb Ischemia in Patients With COVID-19
06/19/2023
Although the link between COVID-19 and ALI has been established, the particularities of the patients remain poorly described and their management not codified because of its emergent character.
Although the link between COVID-19 and ALI has been established, the particularities of the patients remain poorly described and their management not codified because of its emergent character.
Although the link between...
06/19/2023
Vascular Disease Management
Interview
Risk Stratification and Mortality with Large Bore Thrombectomy for Intermediate and High-Risk Pulmonary Embolism
06/19/2023
At SIR 2023, Travis McKenzie, DO presented results from a retrospective cohort study that assessed risk and mortality with large bore thrombectomy for intermediate and high-risk PE.
At SIR 2023, Travis McKenzie, DO presented results from a retrospective cohort study that assessed risk and mortality with large bore thrombectomy for intermediate and high-risk PE.
At SIR 2023, Travis McKenzie, DO...
06/19/2023
Vascular Disease Management
Dr Desai
LINC 2023
Thrombectomy for DVT: Tips on Patient Selection and Procedure
06/07/2023
The questions of when and how to employ thrombectomy for DVT were addressed by Dr Kush Desai during a VIVA@LINC session on Wednesday.
The questions of when and how to employ thrombectomy for DVT were addressed by Dr Kush Desai during a VIVA@LINC session on Wednesday.
The questions of when and how to...
06/07/2023
Vascular Disease Management
Dr Gary Ansel
LINC 2023
FlowTriever Embolectomy for Acute Pulmonary Embolism
06/06/2023
Dr Gary Ansel discusses the FlowTriever System (Inari Medical), the first mechanical thrombectomy device indicated for the treatment of pulmonary embolism.
Dr Gary Ansel discusses the FlowTriever System (Inari Medical), the first mechanical thrombectomy device indicated for the treatment of pulmonary embolism.
Dr Gary Ansel discusses the...
06/06/2023
Vascular Disease Management
Interview
Dual Therapy Following Iliocaval and Iliofemoral Deep Vein Thrombosis Thrombectomy: An Interview With Dr. Gregg Khodorov
05/17/2023
VDM spoke with Dr. Khodorov to discuss the results of the study and what it means for dual therapy regimens for 12-month patency.
VDM spoke with Dr. Khodorov to discuss the results of the study and what it means for dual therapy regimens for 12-month patency.
VDM spoke with Dr. Khodorov to...
05/17/2023
Vascular Disease Management
News
Akura Medical Announces Successful First-in-Human Use of its High Performance Mechanical Thrombectomy Platform
05/10/2023
Initial cases, proctored by 2 leading US interventionalists, mark the first use of mechanical thrombectomy for pulmonary embolism in the Republic of Georgia Akura’s platform, which will be featured at PCR Innovator’s Day, uses a...
Initial cases, proctored by 2 leading US interventionalists, mark the first use of mechanical thrombectomy for pulmonary embolism in the Republic of Georgia Akura’s platform, which will be featured at PCR Innovator’s Day, uses a...
Initial cases, proctored by 2...
05/10/2023
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement